Smerud Medical Research International AS:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Smerud Medical Research International AS - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C7592
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ノルウェー
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥34,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥68,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥102,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Smerud Medical Research International AS (Smerud Medical) is a contract research organization that offers drug development services. The company conducts clinical trials to the pharmaceutical and biotechnology companies for improving new medical compounds. It provides services such as clinical trial management, project funding, consulting, data management and training services. Smerud Medical provides clinical trial management such as planning of clinical development programmes, feasibility studies and closing of trial centres, among others. The company provides project funding services such as research grants, and project strategy. It also provides consulting services such as clinical development programmes, regulatory strategy and ethics, among others. The company operates through its offices located in Sweden, Denmark, Norway, Finland, Poland, Russia, the UK, and others. Smerud Medical is headquartered in Oslo, Norway.

Smerud Medical Research International AS – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Smerud Medical Research International AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Smerud Medical Research International AS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Smerud Medical Research International AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Smerud Medical Research International AS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Smerud Medical Research International AS, Medical Devices Deals, 2012 to YTD 2018 10
Smerud Medical Research International AS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Smerud Medical Research International AS, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
Bionor Enters into Agreement with Smerud Medical Research International 12
Gabather Enters into Agreement with Smerud Medical Research International and Clinical Research Services Turku 13
OptiNose US Enters Into Collaboration with Oslo University Hospital, SINTEF and Smerud Medical Research International 14
Smerud Medical Research International AS – Key Competitors 15
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Smerud Medical Research International AS, Pharmaceuticals & Healthcare, Key Facts 2
Smerud Medical Research International AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Smerud Medical Research International AS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Smerud Medical Research International AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Smerud Medical Research International AS, Deals By Therapy Area, 2012 to YTD 2018 8
Smerud Medical Research International AS, Medical Devices Deals, 2012 to YTD 2018 10
Smerud Medical Research International AS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Bionor Enters into Agreement with Smerud Medical Research International 12
Gabather Enters into Agreement with Smerud Medical Research International and Clinical Research Services Turku 13
OptiNose US Enters Into Collaboration with Oslo University Hospital, SINTEF and Smerud Medical Research International 14
Smerud Medical Research International AS, Key Competitors 15
Smerud Medical Research International AS, Subsidiaries 16

List of Figures
Smerud Medical Research International AS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Smerud Medical Research International AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Smerud Medical Research International AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Smerud Medical Research International AS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Smerud Medical Research International AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Smerud Medical Research International AS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Smerud Medical Research International AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Smerud Medical Research International AS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Smerud Medical Research International AS, Medical Devices Deals, 2012 to YTD 2018 10

★海外企業調査レポート[Smerud Medical Research International AS:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Shionogi & Co., Ltd.:企業のM&A・事業提携・投資動向
    Shionogi & Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Shionogi & Co., Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Life Time Inc:企業の戦略的SWOT分析
    Life Time Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Camping World Holdings Inc (CWH):企業の財務・戦略的SWOT分析
    Camping World Holdings Inc (CWH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • SK Holdings Co Ltd (034730):企業の財務・戦略的SWOT分析
    SK Holdings Co Ltd (034730) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Medicamen Biotech Ltd (531146):企業の財務・戦略的SWOT分析
    Medicamen Biotech Ltd (531146) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Mainstream Renewable Power Ltd:電力:M&Aディール及び事業提携情報
    Summary Mainstream Renewable Power Ltd (Mainstream) is the renewable energy developer. The company is involved in developing, financing, constructing, and operating large-scale renewable energy plants. It also develops and builds onshore and offshore wind and solar power plants. The company sells th …
  • Boehringer Ingelheim GmbH-医療機器分野:企業M&A・提携分析
    Summary Boehringer Ingelheim GmbH (Boehringer), a subsidiary of C. H. Boehringer Sohn AG & Co KG is a pharmaceutical company, which carries out research, development, manufacture and sale of pharmaceuticals. The company offers a wide range of products including prescription medicines, consumer healt …
  • Seven & i Holdings Co., Ltd.:戦略・SWOT・企業財務分析
    Seven & i Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Seven & i Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • nLife Therapeutics SL:製薬・医療:M&Aディール及び事業提携情報
    Summary nLife Therapeutics SL (nLife Therapeutics) is a biopharmaceutical company that discovers and develops cell specific oligonucleotides as therapeutic agents for the treatment of central nervous system and neuromuscular disorders. The company’s lead candidate includes NLF-PD-1233, an oligonucle …
  • Ryosan Company, Ltd:企業の戦略・SWOT・財務分析
    Ryosan Company, Ltd - Strategy, SWOT and Corporate Finance Report Summary Ryosan Company, Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Reliance Insurance Limited:企業の戦略・SWOT・財務情報
    Reliance Insurance Limited - Strategy, SWOT and Corporate Finance Report Summary Reliance Insurance Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Lafarge Malaysia Berhad (LAFMSIA):企業の財務・戦略的SWOT分析
    Summary Lafarge Malaysia Berhad (LMB), formerly Lafarge Malayan Cement Berhad is a construction company that manufactures and markets aggregates, ready-mixed concrete, cement, and related construction and building materials. The company offers cement products such as walcrete, rumah, phoenix, oil we …
  • PT Rekayasa Industri:企業の戦略的SWOT分析
    PT Rekayasa Industri - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Tohoku Electric Power Co Inc (9506):企業の財務・戦略的SWOT分析
    Tohoku Electric Power Co Inc (9506) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Saizeriya Co., Ltd.:企業の戦略・SWOT・財務分析
    Saizeriya Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Saizeriya Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Mechanical Technology Inc (MKTY):企業の財務・戦略的SWOT分析
    Summary Mechanical Technology Inc (MTI) is an electronic equipment company that designs, manufactures, and sells test and measurement instruments and systems. The company offers tools, systems and solutions for markets and applications that require precise measurements and control of products, proce …
  • Juhl Energy Inc:企業の戦略的SWOT分析
    Juhl Energy Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • ECO Animal Health Group Plc (EAH):企業の財務・戦略的SWOT分析
    Summary ECO Animal Health Group Plc (ECO) is a veterinary products manufacturer that offers therapeutic products. The company develops, registers and markets pharmaceutical products and chemicals for animal health markets. ECO produces proprietary patented drugs that are used for the treatment of re …
  • Latvenergo AS:企業の戦略的SWOT分析
    Latvenergo AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Arise AB (ARISE):企業の財務・戦略的SWOT分析
    Arise AB (ARISE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆